Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP362 mRNA | CTD | PMID:22298810 | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of ZNF362 mRNA | CTD | PMID:21179406 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Zfp362 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of ZFP362 exon | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ZNF362 mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ZNF362 mRNA | CTD | PMID:22100608 and PMID:27153756 | alpha-Zearalanol | multiple interactions | ISO | Zfp362 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ZFP362 mRNA | CTD | PMID:35163327 | amphetamine | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of ZFP362 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of ZNF362 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of ZNF362 mRNA | CTD | PMID:33212167 | azathioprine | decreases expression | EXP | | 6480464 | Azathioprine results in decreased expression of ZNF362 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP362 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF362 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZNF362 mRNA | CTD | PMID:21632981 more ... | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZNF362 mRNA | CTD | PMID:25047013 | bisphenol A | increases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZFP362 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | ISO | Zfp362 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of ZFP362 promoter | CTD | PMID:27312807 | bisphenol A | increases methylation | ISO | Zfp362 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of ZFP362 gene | CTD | PMID:28505145 | buta-1,3-diene | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of ZFP362 mRNA | CTD | PMID:29038090 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of ZNF362 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF362 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF362 mRNA | CTD | PMID:35301059 | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of ZNF362 protein | CTD | PMID:35688186 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of ZNF362 mRNA | CTD | PMID:16002434 | carbon nanotube | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Chlorpyrifos results in decreased expression of ZFP362 mRNA | CTD | PMID:27905518 | chlorpyrifos | increases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ZFP362 mRNA | CTD | PMID:37019170 | chlorpyrifos | multiple interactions | ISO | Zfp362 (Rattus norvegicus) | 6480464 | [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of ZFP362 mRNA | CTD | PMID:27905518 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZNF362 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of ZNF362 protein | CTD | PMID:35688186 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ZNF362 mRNA | CTD | PMID:20106945 and PMID:25562108 | decabromodiphenyl ether | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in decreased expression of ZFP362 mRNA | CTD | PMID:23640034 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF362 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | ISO | Zfp362 (Mus musculus) | 6480464 | Ethanol affects the splicing of ZFP362 mRNA | CTD | PMID:30319688 | Ethylenethiourea | multiple interactions | ISO | Zfp362 (Rattus norvegicus) | 6480464 | [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of ZFP362 mRNA | CTD | PMID:27905518 | fipronil | increases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | fipronil results in increased expression of ZFP362 mRNA | CTD | PMID:34044035 | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of ZNF362 protein | CTD | PMID:37730182 | gentamycin | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZFP362 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of ZNF362 mRNA | CTD | PMID:20044591 | indole-3-methanol | affects expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | indole-3-carbinol affects the expression of ZFP362 mRNA | CTD | PMID:21396975 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of ZNF362 mRNA | CTD | PMID:35811015 | methoxychlor | affects methylation | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of ZFP362 gene | CTD | PMID:35440735 | monosodium L-glutamate | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Sodium Glutamate results in decreased expression of ZFP362 mRNA | CTD | PMID:22078008 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZNF362 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ZFP362 mRNA | CTD | PMID:33387578 | pentachlorophenol | increases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of ZFP362 mRNA | CTD | PMID:23892564 | perfluorooctanoic acid | multiple interactions | ISO | Zfp362 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ZFP362 mRNA | CTD | PMID:35163327 | pirinixic acid | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ZFP362 mRNA | CTD | PMID:23811191 | propiconazole | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | propiconazole results in decreased expression of ZFP362 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ZNF362 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF362 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF362 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of ZFP362 mRNA | CTD | PMID:19073995 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of ZNF362 protein | CTD | PMID:30528433 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of ZNF362 mRNA | CTD | PMID:31758290 | testosterone | increases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of ZFP362 mRNA | CTD | PMID:33848595 | thioacetamide | decreases expression | ISO | Zfp362 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of ZFP362 mRNA | CTD | PMID:34492290 | troglitazone | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | troglitazone results in decreased expression of ZNF362 mRNA | CTD | PMID:28973697 | tungsten | decreases expression | ISO | Zfp362 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ZFP362 mRNA | CTD | PMID:30912803 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZNF362 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ZNF362 gene | CTD | PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ZNF362 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF362 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF362 mRNA | CTD | PMID:27188386 | |